Literature DB >> 23929769

Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?

Jason Grebely1, Bart Grady, Behzad Hajarizadeh, Kimberly Page, Gregory J Dore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23929769      PMCID： PMC3918244          DOI： 10.1002/hep.26675

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Authors:  T Poynard; V Ratziu; F Charlotte; Z Goodman; J McHutchison; J Albrecht
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

2.  Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.

Authors:  Lin Liu; Brian E Fisher; David L Thomas; Andrea L Cox; Stuart C Ray
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

3.  Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.

Authors:  Mazen Noureddin; Elizabeth C Wright; Harvey J Alter; Shauna Clark; Emmanuel Thomas; Richard Chen; Xiongce Zhao; Cathy Conry-Cantilena; David E Kleiner; T Jake Liang; Marc G Ghany
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

4.  Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.

Authors:  Jason Grebely; Meghan D Morris; Thomas M Rice; Julie Bruneau; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Naglaa H Shoukry; Georg Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Maria Prins; Gregory J Dore; Kimberly Page
Journal:  Int J Epidemiol       Date:  2012-11-30       Impact factor: 7.196

5.  HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.

Authors:  Lorenzo Uccellini; Fan-Chen Tseng; Alessandro Monaco; Fatma M Shebl; Ruth Pfeiffer; Myhanh Dotrang; Dianna Buckett; Michael P Busch; Ena Wang; Brian R Edlin; Francesco M Marincola; Thomas R O'Brien
Journal:  Hepatology       Date:  2012-06-01       Impact factor: 17.425
  5 in total
  3 in total

1.  Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types.

Authors:  François M J Lamoury; Sofia Bartlett; Brendan Jacka; Behzad Hajarizadeh; Jason Grebely; Gail V Matthews; Gregory J Dore; Tanya L Applegate
Journal:  J Mol Diagn       Date:  2015-07-04       Impact factor: 5.568

2.  Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons.

Authors:  Melanie R Walker; Hui Li; Suzy Teutsch; Brigid Betz-Stablein; Fabio Luciani; Andrew R Lloyd; Rowena A Bull
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

Review 3.  Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.

Authors:  Daniel Fuster; Arantza Sanvisens; Ferran Bolao; Inmaculada Rivas; Jordi Tor; Robert Muga
Journal:  World J Hepatol       Date:  2016-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.